79685-17-9

Usage

Uses

Used in Organic Synthesis:
5-Bromo-2-(methylsulfinyl)pyrimidine is used as a building block in organic synthesis for the creation of more complex molecules. Its unique structure allows for the development of a variety of chemical entities with diverse applications.
Used in Pharmaceutical Research:
In pharmaceutical research, 5-Bromo-2-(methylsulfinyl)pyrimidine serves as a valuable starting material for the synthesis of various pharmaceutical compounds. Its structural features make it a promising candidate for the development of new drugs with potential therapeutic benefits.
Used as a Reagent in Chemical Reactions:
5-Bromo-2-(methylsulfinyl)pyrimidine may also be utilized as a reagent in chemical reactions, facilitating the synthesis of a range of chemical products and contributing to the advancement of chemical research and development.
Used in the Synthesis of Biologically Active Compounds:
Due to its potential biological and pharmacological activities, 5-Bromo-2-(methylsulfinyl)pyrimidine can be employed in the synthesis of biologically active compounds. This may lead to the discovery of new therapeutic agents with significant applications in medicine.

Upstream product

• 14001-67-3 5-bromo-2-methylthiopyrimidine 

Downstream Products

• 38275-48-8 5-bromo-2-(methylsulfonyl)pyrimidine 

Relevant academic research and scientific papers

Highly Chemoselective and Enantioselective Catalytic Oxidation of Heteroaromatic Sulfides via High-Valent Manganese(IV)-Oxo Cation Radical Oxidizing Intermediates

A manganese complex with a porphyrin-like ligand that catalyzes the highly chemoselective and enantioselective oxidation of heteroaromatic sulfides, including imidazole, benzimidazole, indole, pyridine, pyrimidine, pyrazine, sym-triazine, thiophene, thiaz

Pyrimidine-2-sulphides and their S-oxides for use in medicine and methods of use therefor, pharmaceutical compositions containing them, processes for their preparation and per se novel sulphides and S-oxides

Compounds of the formula STR1 (wherein X represents a halogen atom; n is 0, 1 or 2; R1 and R2, which may be the same or different, each represents a hydrogen atom or a carboxyl, esterified carboxyl, amido or mono- or di-C1-4 alkylamido group or a C1-4 alkyl group which may if desired carry a carboxyl or esterified carboxyl group; and R3 represents a C1-32 saturated or unsaturated, straight or branched, cyclic or acyclic aliphatic group or an araliphatic or heterocyclic substituted aliphatic group, a heterocyclic group or an aryl group which groups may if desired carry one or more substituents selected from halogen atoms and oxo, nitro, hydroxy, etherified hydroxy, esterified hydroxy, primary, secondary or tertiary amino, acylamino etherified mercapto or S=O or --SO2 derivatives thereof and esterified phosphonic acid groups) and, where an acidic or basic group is present, physiologically compatible salts thereof have been found to be of use in combating abnormal cell proliferation. The compounds are prepared inter alia by oxidation of the corresponding sulfide, displacement of a leaving atom or group from the 2-position of the pyrimidine by reaction with a sulfinic acid or by ring closure of the pyrimidine ring.